Advertisement
Loading...

Clene Inc.

CLNN•NASDAQ
Healthcare
Biotechnology
$7.05
$0.55(8.46%)
U.S. Market opens in 14h 44m

Clene Inc. (CLNN) Stock Overview

Explore Clene Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap69.6M
P/E Ratio-2.36
EPS (TTM)$-2.65
ROE2.34%
Fundamental Analysis

AI Price Forecasts

1 Month$4.03
3 Months$4.01
1 Year Target$2.01

CLNN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Clene Inc. (CLNN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.36 and a market capitalization of 69.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.08%
5-Day Change
-6.70%
1-Month Change
4.19%
3-Month Change
64.54%
6-Month Change
-18.31%
Year-to-Date (YTD) Change
18.57%
1-Year Change
161.65%
3-Year Change
-61.12%
5-Year Change
-95.23%
All-Time (Max) Change
-96.43%

Contact Information

https://clene.com
801 676 9695
6550 South Millrock Drive, Salt Lake City, UT, 84121

Company Facts

75 Employees
IPO DateOct 18, 2018
CountryUS
Actively Trading

Frequently Asked Questions